Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling advanced prostate cancer. Experts at The Institute of Cancer Research, London, ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before the cancer comes back. Researchers at UCLA have found that a blend of a ...

For the first time, patients whose prostate cancer has not spread will be eligible for the drug abiraterone in England, after NHS chiefs widened access to the treatment. Around 2,000 men diagnosed ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, researchers found in a clinical trial. File Photo by Brian Kersey/UPI A powerful new ...

– 32nd Annual Scientific Retreat brought together 600+ prostate cancer researchers and leaders to spotlight breakthrough discoveries and advance cutting-edge science – – PCF continues to be the ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug ...

ZERO Prostate Cancer (ZERO), announces the 2026 Veterans' Action Convening, a national gathering committed to strengthening prostate cancer care, support, and outcomes for veterans. Taking place ...